Liu Rixiang, Su Ruolin, Yan Haiyu, Zhu Huangxin, Zhang Nuobei
Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Jiangxi, China.
Medicine (Baltimore). 2024 Dec 20;103(51):e41029. doi: 10.1097/MD.0000000000041029.
Pancreaticopleural fistula (PPF) is an infrequent etiology of pleural effusion, characterized by nonspecific thoracic symptoms, which often leads to misdiagnosis and subsequent severe complications. Consequently, early diagnosis is crucial for effective management and the prevention of adverse outcomes. This report presents a rare case of PPF causing bilateral pleural effusions, aiming to enhance clinical recognition of this condition.
A 51-year-old male with a history of hepatitis B, pulmonary tuberculosis, and chronic pancreatitis presented with recurrent chest tightness, dyspnea, and significant weight loss. He had undergone multiple hospitalizations for pleural effusions with no definitive diagnosis.
The patient exhibited a marked increase in amylase levels within the pleural effusion, and magnetic resonance cholangiopancreatography revealed a pancreatic pseudocyst herniating into the mediastinum. Endoscopic retrograde cholangiopancreatography (ERCP) demonstrated mild dilation of the pancreatic duct, leading to a definitive diagnosis of PPF.
Despite initial conservative measures, including thoracentesis, antimicrobial therapy, and somatostatin analogs, the patient continued to experience persistent pleural effusion. Ultimately, ERCP with pancreatic duct stent placement was performed, leading to a significant improvement in the patient's condition.
Re-evaluation 2 months postdischarge using a thoracoabdominal computed tomography scan confirmed near-complete resolution of the pancreatic pseudocyst, absence of pleural effusion, and normalization of pancreatic function.
This case underscores the importance of a multidisciplinary approach in diagnosing and managing PPF. It highlights the utility of ERCP in both diagnosing and treating PPF and the need for early recognition to prevent diagnostic delays and improve patient outcomes.
胰胸膜瘘(PPF)是胸腔积液的一种罕见病因,其特征为非特异性胸部症状,常导致误诊及随后的严重并发症。因此,早期诊断对于有效治疗及预防不良后果至关重要。本报告介绍了一例罕见的由PPF引起双侧胸腔积液的病例,旨在提高对该病症的临床认识。
一名51岁男性,有乙肝、肺结核及慢性胰腺炎病史,出现反复胸闷、呼吸困难及显著体重减轻。他因胸腔积液多次住院,但未明确诊断。
患者胸腔积液中淀粉酶水平显著升高,磁共振胰胆管造影显示胰腺假性囊肿突入纵隔。内镜逆行胰胆管造影(ERCP)显示胰管轻度扩张,最终确诊为PPF。
尽管最初采取了包括胸腔穿刺、抗菌治疗及生长抑素类似物等保守措施,但患者仍持续存在胸腔积液。最终,进行了ERCP并放置胰管支架,患者病情显著改善。
出院2个月后通过胸腹计算机断层扫描复查证实胰腺假性囊肿几乎完全消退,无胸腔积液,胰腺功能正常。
该病例强调了多学科方法在PPF诊断和治疗中的重要性。它突出了ERCP在PPF诊断和治疗中的作用,以及早期识别以防止诊断延误和改善患者预后的必要性。